Provisional Patent Lodged with USPTO for NanoBodies Platform
Filed with ASX · · 2 pages · English
Earlier from Argent Biopharma
- CannEpil - Largest Commercial Shipment Arrives in Ireland
- Quarterly Activities/Appendix 4C Cash Flow Report
- Streamlined Acquisition of AusCann Assets
- A$11m Financing Facility to Complete Strategic Acquisition
- Appendix 4E and 2025 Annual Report
Later from Argent Biopharma
- Half Yearly Report and Accounts
- RGT Executes Global CannEpil Licensing Deal for US$5.5M
- CannEpil Global Licence Expands into Veterinary Healthcare
- Notification of cessation of securities - RGT
- US Veterinary Development Programme for CannEpil Commences
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma